The Akt isoforms, their unique functions and potential as anticancer therapeutic targets
Akt (also known as protein kinase B or PKB) is the major downstream nodal point of the PI3K signaling pathway. This pathway is a promising anticancer therapeutic target, because constitutive activation of the PI3K-Akt pathway is correlated with tumor development, progression, poor prognosis, and res...
Main Authors: | Santi Stacey A., Douglas Alison C., Lee Hoyun |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2010-12-01
|
Series: | Biomolecular Concepts |
Subjects: | |
Online Access: | https://doi.org/10.1515/bmc.2010.035 |
Similar Items
-
Distinct functions of AKT isoforms in breast cancer: a comprehensive review
by: Nico Hinz, et al.
Published: (2019-11-01) -
Evaluation of the therapeutic potential of Akt inhibition in a translational model of histiocytic sarcoma
by: Qin, Qizhi
Published: (2020) -
PI3K/Akt signaling pathway and hepatic fibrosis
by: PAN Peng
Published: (2013-05-01) -
Marine compounds targeting the PI3K/Akt signaling pathway in cancer therapy
by: Jiaen Wei, et al.
Published: (2020-09-01) -
Mytoxin B and Myrothecine A Induce Apoptosis in Human Hepatocarcinoma Cell Line SMMC-7721 via PI3K/Akt Signaling Pathway
by: Huiliang Song, et al.
Published: (2019-06-01)